Research Progress of EGFR T790M Mutation in Non-small Cell Lung Cancer
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) could improve the prognosis of patients with EGFR-mutated non-small cell lung cancer (NSCLC). With the application of TKIs, gene detection found that more and more patients were with EGFR T790M mutations, which significantly aff...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-06-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.0302.htm |